(Q67906709)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838661%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838661%20AND%20SRC:MED&resulttype=core&format=json

Orthopedics and sports medicine

19 September 2019

main subject

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

6 December 2022

author name string

R. C. Mühlbauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838661

6 December 2022

F. Bauss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838661

6 December 2022

R. Schenk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838661

6 December 2022

M. Janner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838661

6 December 2022

E. Bosies

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838661

6 December 2022

K. Strein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838661

6 December 2022

H. Fleisch

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838661

6 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1838661

6 December 2022

publication date

1 September 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838661%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjbmr.5650060915

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

https://onlinelibrary.wiley.com/doi/full/10.1002/jbmr.5650060915

6 December 2022

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Journal of Bone and Mineral Research

6 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838661%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838661%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

1003-1011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838661%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838661%20AND%20SRC:MED&resulttype=core&format=json

Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised r

6 December 2022

2

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

6 December 2022

3

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo.

6 December 2022

4

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats

6 December 2022

5

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Diphosphonates and Page's disease of bone.

6 December 2022

6

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Rationale for diphosphonate therapy in hypercalcemia of malignancy. Introduction

6 December 2022

8

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

6 December 2022

12

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

6 December 2022

13

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone

6 December 2022

15

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.

6 December 2022

16

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man

6 December 2022

18

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.

6 December 2022

19

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats. New model to study bone resorption in vivo

6 December 2022

23

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice

6 December 2022

24

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Short- and long-term effects of a single dose of bisphosphonates on retinoid-induced bone resorption in thyroparathyroidectomized rats

6 December 2022

29

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone

6 December 2022

30

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse

6 December 2022

31

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone

6 December 2022

33

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro

6 December 2022

34

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy

6 December 2022

35

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650060915

6 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838661%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference